viernes, 8 de mayo de 2026

Challenges in escalating social prescribing where most needed The Lancet Primary Care ++... ++

Challenges in escalating social prescribing where most needed The Lancet Primary Care https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00058-0/fulltext?dgcid=raven_jbs_etoc_email Apr 2026 Volume 2Number 4 https://www.thelancet.com/journals/lanprc/issue/vol2no4/PIIS3050-5143(26)X2004-0 Kidney outcomes with GLP-1 receptor agonists in people with type 2 diabetes already receiving SGLT2 inhibitors: a target trial emulation study using UK primary care data Thijs T Jansz, PhDa Send email to t.jansz@exeter.ac.uk ∙ Andrew P McGovern, MDa ∙ Katherine G Young, PhDa ∙ Martha M Dinsdale, MSca ∙ Pedro Cardoso, PhDa ∙ Beverley M Shields, PhDa ∙ et al. https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00034-8/fulltext?dgcid=raven_jbs_etoc_feature_lanprc Nationwide audit and feedback to reduce overuse of pathology tests among high-requesting general practitioners in Australia: a factorial, cluster-randomised, controlled trial Prof Denise A O’Connor, PhDa Send email to denise.oconnor@monash.edu ∙ Prof Paul Glasziou, PhDb ∙ Dina Schram, PGDipPsychc ∙ Alexandra Gorelik, MSca ∙ Amelia Elwick, PGDipPsychc ∙ Prof Kirsten McCaffery, PhDd ∙ et al. https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(26)00035-X/fulltext?dgcid=raven_jbs_etoc_feature_lanprc

No hay comentarios:

Publicar un comentario